The big insult is why private and governmental agencies give license to over-priced medicines when the costs of research and development are born by the public? An example is a drug to cure hepatitis C that was largely developed with public funds but its patents rights were assigned to private entities.
Drug companies come up with these exorbitant prices by factoring the life-long cost of symptom treatment against their one-time cure.
https://www.lewrockwell.com/2018/04/bill-sardi/moonshot-medicine-who-can-afford-it/
By Bill Sardi
It is all part of the 21st Century Cures Act, which spreads $4.8 billion of research funding in an attempt to accelerate the development and approval of real cures. But will this Herculean effort bankrupt insurance pools?
The money is being directed toward expensive pharmacological cures that will further burst the Medicare Trust fund. Gobs of federal money are going towards innovations, like CRISPR gene therapy, that intends to completely remedy single-gene mutation diseases like cystic fibrosis, sickle cell, Huntington’s disease, and muscular dystrophy, all cured in a single treatment. But at what cost? Read the rest of this entry »
MCViewPoint 